Table 3 |
||||
|
Cost of blister-packaged artesunate and mefloquine |
||||
| Drug package |
Actual cost (at 9.5% productivity) |
Potential cost (at full productivity) |
||
|
|
||||
| Recurrent costs |
Recurrent and capital costs |
Recurrent costs |
Recurrent and capital costs |
|
|
|
||||
| A+M2 (Art 50 mg × 6 + Mef 250 mg × 2) |
2.307 |
2.595 |
1.386 |
1.420 |
| A+M3* (Art 50 mg × 9 + Mef 250 mg × 3) |
2.894 |
3.182 |
1.973 |
2.007 |
| A+M4 (Art 50 mg × 12 + Mef 250 mg × 4) |
3.480 |
3.769 |
2.560 |
2.594 |
| Malarine® (adult) (Art 200 mg × 3 + Mef 250 mg × 4) |
3.608 |
3.896 |
2.688 |
2.722 |
|
|
||||
|
*Same cost for Malarine junior ® |
||||
|
Yeung et al. Malaria Journal 2008 7:84 doi:10.1186/1475-2875-7-84 |
||||
